Skip to content
Lower risk Drug recall · FDA · Published December 20, 2019

CoValence Laboratories PCA Skin Blemish Control Bar Recall: High Salicylic Acid Content

CoValence Laboratories recalls PCA Skin Blemish Control Bar (3.2 oz) due to excessive salicylic acid content. This may cause skin irritation or other adverse effects. Consumers should check product details and contact the company for guidance.

🇺🇸 FDA recall #D-0634-2020DrugCoValence Laboratories ›
Take action

Contact the company

Recalling firmIsland Kinetics, Inc. d.b.a. CoValence Laboratories460 S Benson Ln Ste 1-3 · Chandler, AZ 85224-5663
✎ GovInfoNow plain-language explainer

What happened, in plain English

CoValence Laboratories is recalling their PCA Skin Blem:ish Control Bar acne cleanser because it contains too much salicylic acid. This could cause skin irritation or other adverse reactions. The recall affects products distributed by PCA Skin with specific batch numbers. Read more at govinfonow.com/recall/37575-covalence-laboratories-pca-skin-blemish-control-bar-recall-high-salicylic.

Source Summary by GovInfoNow · govinfonow.com/recall/37575-covalence-laboratories-pca-skin-blemish-control-bar-recall-high-salicylic · Updated October 5, 2026 · FDA enforcement record: FDA #D-0634-2020

Cite this page

“CoValence Laboratories PCA Skin Blemish Control Bar Recall: High Salicylic Acid Content.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37575-covalence-laboratories-pca-skin-blemish-control-bar-recall-high-salicylic. Based on FDA recall #D-0634-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0634-2020%22&limit=1).

Why it’s dangerous

The product contains salicylic acid at a concentration higher than the manufacturer's specifications. This can lead to skin irritation, redness, or other adverse reactions in some users, especially those with sensitive skin.

Who’s affected

People who own or use the PCA Skin Blemish Control Bar acne cleanser with the specified batch number are affected. Those with sensitive skin may be at higher risk of irritation.

How to tell if you have this one

Check for the product name 'PCA Skin Blemish Control Bar', 3.2 oz/90g, with batch number L041918A and expiration date 04/2021. The product was distributed by PCA Skin in Scottsdale, AZ.

  • Brand
    CoValence Laboratories
  • Product
    PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only, Distributed by PCA
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the batch number L041918A and expiration date 04/2021 on the product label.

Where it went and when

Where it was distributed

Distributed in Arizona.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: yesAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “AZ” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Arizona.

Recall timeline

FDA terminated this recall 20 months after the firm started it.

1. Firm started the recall: Dec 20, 201912. FDA classified it Class III: Dec 31, 201923. Published in FDA’s Enforcement Report: Jan 8, 202034. FDA terminated the recall: Aug 25, 2021420192021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0634-2020 (December 20, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0634-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA